电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

ULBP3 抗体

(UL16 Binding Protein 3 (ULBP3))
Ligand for the NKG2D receptor, together with at least ULBP1 and ULBP2. ULBPs activate multiple signaling pathways in primary NK cells, resulting in the production of cytokines and chemokines. Binding of ULBPs ligands to NKG2D induces calcium mobilization and activation of the JAK2, STAT5, ERK and PI3K kinase/Akt signal transduction pathway. Has lower affinity for NKG2D compared to ULBP1 and ULBP2 and induces weaker signaling responses than does ULBP2 or ULBP1.

3 results

ULBP3 适用: 人 ELISA, WB 宿主: 兔 Polyclonal unconjugated
产品编号 ABIN6389787
 
ULBP3 适用: 人 FACS 宿主: 小鼠 Monoclonal PE
产品编号 ABIN797296
 
ULBP3 适用: 人 WB, Neut 宿主: 小鼠 Monoclonal MM0594-6E12 unconjugated
产品编号 ABIN1983478
 
  • 类型 Primary
    • Primary
  • 应用范围
    • Western Blotting (WB)
    • ELISA
    • Flow Cytometry (FACS)
    • Neutralization (Neut)
  • 适用
    • Human
  • 图像
  • 抗体来源
    • Mouse
    • Rabbit
  • 克隆形成能力
    • Monoclonal
    • Polyclonal
  • 克隆
    • MM0594-6E12
  • 抗原表位
    • AA 27-216
  • 标记
    • 非结合性
    • PE
  • 抗体亚型
    • IgG
    • IgG2
    • IgG2a
  • Format
    • Liquid
    • Lyophilized
  • Supplier
    • antibodies-online
    • Angio-Proteomie

Latest Publications for our ULBP3 抗体

Tanaka, Nakazawa, Nakamura, Nishimura, Matsuda, Omoto, Shida, Murakami, Nakagawa, Motoyama, Morita, Tsujimura, Nakase: "Ex vivo-expanded highly purified natural killer cells in combination with temozolomide induce antitumor effects in human glioblastoma cells in vitro." in: PLoS ONE, Vol. 14, Issue 3, pp. e0212455, (2019) (PubMed).

Tremblay-McLean, Coenraads, Kiani, Dupuy, Bernard: "Expression of ligands for activating natural killer cell receptors on cell lines commonly used to assess natural killer cell function." in: BMC immunology, Vol. 20, Issue 1, pp. 8, (2019) (PubMed).

Chollat-Namy, Ben Safta-Saadoun, Haferssas, Meurice, Chouaib, Thiery: "The pharmalogical reactivation of p53 function improves breast tumor cell lysis by granzyme B and NK cells through induction of autophagy." in: Cell death & disease, Vol. 10, Issue 10, pp. 695, (2019) (PubMed).

Najar, Fayyad-Kazan, Meuleman, Bron, Fayyad-Kazan, Lagneaux: "Mesenchymal stromal cells of the bone marrow and natural killer cells: cell interactions and cross modulation." in: Journal of cell communication and signaling, Vol. 12, Issue 4, pp. 673-688, (2018) (PubMed).

Tremblay-McLean, Bruneau, Lebouché, Lisovsky, Song, Bernard: "Expression Profiles of Ligands for Activating Natural Killer Cell Receptors on HIV Infected and Uninfected CD4⁺ T Cells." in: Viruses, Vol. 9, Issue 10, (2017) (PubMed).

Huang, Easom, Tang, Gill, Singh, Robertson, Chang, Trowsdale, Davidson, Rosenberg, Fusai, Toubert, Kennedy, Peppa, Maini: "T Cells Infiltrating Diseased Liver Express Ligands for the NKG2D Stress Surveillance System." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 198, Issue 3, pp. 1172-1182, (2017) (PubMed).

Chen, Zhu, Xu, Fang, Zhao: "Expression and prognostic significance of unique ULBPs in pancreatic cancer." in: OncoTargets and therapy, Vol. 9, pp. 5271-9, (2016) (PubMed).

Son, Lee, Koh, Shin, Bae, Yang, Park: "Combination treatment with decitabine and ionizing radiation enhances tumor cells susceptibility of T cells." in: Scientific reports, Vol. 6, pp. 32470, (2016) (PubMed).

Vasu, He, Cheney, Gopalakrishnan, Mani, Lozanski, Mo, Groh, Whitman, Konopitzky, Kössl, Bucci, Lucas, Yu, Caligiuri, Blum, Adam, Borges, Rueter, Heider, Marcucci, Muthusamy: "Decitabine enhances anti-CD33 monoclonal antibody BI 836858-mediated natural killer ADCC against AML blasts." in: Blood, Vol. 127, Issue 23, pp. 2879-89, (2016) (PubMed).

Osterburg, Nelson, Yaniv, Foot, Donica, Nashu, Liu, Wikenheiser-Brokamp, Moss, Gupta, McCormack, Borchers: "NK cell activating receptor ligand expression in lymphangioleiomyomatosis is associated with lung function decline." in: JCI insight, Vol. 1, Issue 16, pp. e87270, (2016) (PubMed).

Aliases for ULBP3 抗体

UL16 binding protein 3 (ULBP3) 抗体
RAET1N 抗体
You are here:
Chat with us!